文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Development of Human Cloned Blastocysts Following Somatic Cell
侵权投诉

Development of Human Cloned Blastocysts Following Somatic Cell

TECHNOLOGY DEVELOPMENT Development of Human Cloned Blastocysts Following Somatic Cell Nuclear Transfer with Adult Fibroblasts ANDREW J. FRENCH,a CATHARINE A. ADAMS,b LINDA S. ANDERSON,b JOHN R. KITCHEN,c MARCUS R. HUGHES,c SAMUEL H. WOODa,b a c

Stemagen Corporation, La Jolla, California, USA; bThe Reproductive Sciences Center, La Jolla, California, USA; Genesis Genetics Institute, LLC, Detroit, Michigan, USA

Key Words. Egg donation Nuclear transfer Human Embryo Somatic cell nuclear transfer Oocytes Blastocysts

ABSTRACT Nuclear transfer stem cells hold considerable promise in the field of regenerative medicine and cell-based drug discovery. In this study, a total of 29 oocytes were obtained from three young (20–24 years old) reproductive egg donors who had been successful in previous cycles. These oocytes, deemed by intended parents to be in excess of their reproductive needs, were donated for research without financial compensation by both the egg donor and intended parents after receiving informed consent. All intended parents successfully achieved ongoing pregnancies with the oocytes retained for reproductive purposes. Mature oocytes, obtained within 2 hours following transvaginal aspiration, were enucleated using one of two methods, extrusion or aspiration, after 45 minutes of incubation in cytochalasin B. Rates of oocyte lysis or degeneration did not differ between the two methods. Somatic cell nuclear transfer (SCNT) embryos were constructed using two established adult male fibroblast lines of normal karyotype. High rates of pronuclear formation (66%), early cleavage (47%), and blastocyst (23%) development were observed following incubation in standard in vitro fertilization culture media. One cloned blastocyst was confirmed by DNA and mitochondrial DNA fingerprinting analyses, and DNA fingerprinting of two other cloned blastocysts indicated that they were also generated by SCNT. Blastocysts were also obtained from a limited number of parthenogenetically activated oocytes. This study demonstrates, for the first time, that SCNT can produce human blastocyst-stage embryos using nuclei obtained from differentiated adult cells and provides new information on methods that may be needed for a higher level of efficiency for human nuclear transfer. STEM CELLS 2008;26:485– 493

Disclosure of potential conflicts of interest is found at the end of this article. Importantly, this involved an undifferentiated hESC donor cell, rather than an adult cell. Lu et al. also reported having cloned human embryos using fetal fibroblasts and granulosa cells, although the reliability of the finding is uncertain since no DNA fingerprinting of the cloned blastocysts was provided[16]. Other preliminary reports have generated only early cleavage stage nuclear transfer embryos[17, 18] using cytoplasts obtained from both in vitro and in vivo maturation and aged human in vitro fertilization (IVF) oocytes that had failed-to-fertilize[18, 19

]. Clearly, a number of significant hurdles need to be addressed if SCNT is to lead to the successful application of cell-based therapies using autologous hESC lines. The scarcity of donated mature human metaphase II oocytes available for research is a significant impediment. Using an alternative source of failed-to-fertilize human oocytes obtained at 16–18 hours postinsemination[19] or 48 hours after retrieval[20] resulted in cleavage abnormalities and early-embryonic arrest, primarily as a consequence of aneuploidy and spindle defects. These types of oocytes also appear to be more difficult to enucleate and fuse compared with freshly recovered human oocytes[20]. The use of aged oocytes has been reported to support embryonic nuclear remodeling and reprogramming to various degrees in the rabbit[21], mouse[22], and bovine[23]. However, failed-to-fertilize human oocytes may show irreversible cytoplasmic aging effects

INTRODUCTION The consistent and efficient generation of both heterologous and autologous stem cells using somatic cell nuclear transfer (SCNT) has the potential to revolutionize our understanding and development of treatments for degenerative diseases[1–10]. The recent voluntary withdrawal, amid allegations of scientific impropriety, of publications that claimed successful human nuclear transfer[11] suggests that a reassessment of the critical pathways to performing successful SCNT with human oocytes is required. Somatic cell nuclear transfer in mammals was first performed in the early 1980s, and numerous approaches have been used to achieve the four major steps involved in the nuclear transfer procedure (reviewed in[12–14]). These four steps are preparation of recipient cytoplasts (enucleated oocytes), preparation of donor DNA, transfer of the donor DNA into the cytoplast, and resumption of embryonic development by parthenogenetic activation, all of which must be completed without damaging the donor nucleus or the host oocyte/cellular integrity. Derivation of cloned human embryos from SCNT techniques remains in its infancy, with the only reliable publication describing the generation of a single cloned blastocyst, which did not produce a human embryonic stem cell (hESC) line[15].

Correspondence: Andrew J. French, Ph.D., Stemagen Corp., 4150 Regents Park Row, La Jolla, California 92037, USA. Telephone: 858-453-2305; Fax: 858-754-1295; e-mail: afrench@stemagen.com Received April 4, 2007; accepted for publication January 3, 2008; first published online in STEM CELLS EXPRESS January 17, 2008. available online without subscription through the open access option.©AlphaMed Press 1066-5099/2008/$30.00/0 doi: 10.1634/stemcells.2007-0252

STEM CELLS 2008;26:485– 493 doc.guandang.net

Development of Human Cloned Blastocysts Following Somatic Cell

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email